Observational studyFrontiers in endocrinology2025

The potential biomarker value of soluble CD36 in the treatment of diabetic kidney disease: evidence from GLP-1 and insulin interventions.

Wenxuan Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.